成都治疗腿血栓成都哪所医院治疗下肢动脉硬化好,成都蛋蛋静脉曲张哪个医院治的好,精索静脉曲张在成都找哪家医院治疗,成都治疗糖足去哪家医院好,成都的血栓医院,成都哪里有治疗睾丸精索静脉曲张的,成都静脉血栓手术都多少钱

SCOTTSDALE, Arizona — An Arizona woman is facing first degree murder charges after she admitted to murdering her mother Monday afternoon.According to Sgt. Ben Hoster, dispatchers received a call around 2 p.m. from someone at an apartment complex near 64th Street and Osborn Road saying their neighbor asked them to call 911.Scottsdale police say Holly Brennan, 46, later told the dispatcher that she had killed her mother, Sharon Simmons. Officers responded and found Simmons deceased in a bed.Brennan told police she suffocated her mother. Investigators did not immediately know when Simmons had died.Mike Bennett said he saw Brennan confess to police outside her apartment. "She admitted that she smothered her mother with a pillow," said Bennett. "Responding officers then went inside the apartment and located an elderly female deceased on the bed," said Sgt. Hoster. "Then they put the cuffs on her and sat her down on the sidewalk," said Bennett. "I couldn't believe what I was hearing. It took a couple seconds for it to sink in, and I'm like, 'Wow she just admitted that!'" 1093

Rod Rosenstein took aim at James Comey Monday, calling him a "partisan pundit" in prepared remarks for a speech that included the most public retelling yet of the twists and turns of the Russia investigation by the man who oversaw it.Speaking to a group of business and civic leaders in Baltimore, the former deputy attorney general -- just days removed from a tumultuous tenure at the Department of Justice -- recounted how he had prepared a memo in 2017 that supported President Donald Trump's firing of Comey, then the FBI director, and defended his decision to appoint Robert Mueller as a special counsel in the wake of that firing.Rosenstein also responded directly to a barb from the former FBI director, who said at a CNN town hall last week that Rosenstein's character wasn't strong and that his soul had been "eaten" by his time in the Trump administration."Now the former director is a partisan pundit, selling books and earning speaking fees while speculating about the strength of my character and the fate of my immortal soul. That is disappointing," Rosenstein said.In his speech before a crowd of nearly 1,000 people at the annual Greater Baltimore Committee dinner, Rosenstein acknowledged the unusual role he played in the drama of Trump's Washington -- as a Republican held up by the left for stewarding the Mueller probe."People spend a lot of time debating whose side I was on, based on who seemed to benefit most from any individual decision," Rosenstein said. "But trying to infer partisanship from law enforcement decisions is a category error. It uses the wrong frame of reference."On Monday, with the frame of hindsight, Rosenstein told the audience why he disagreed with Comey's handling of the Hillary Clinton email investigation, and how he put those concerns in a memo at Trump's request.Rosenstein also remembered how he disobeyed Trump's request to include in that memo that Comey had told Trump that he wasn't under investigation -- "because, one, I had no personal knowledge of what the director said, and two, in any event, it was not relevant to my memo" -- and criticized the way the President carried out the firing."If I had been the decisionmaker, the removal would have been handled very differently, with far more respect and far less drama," Rosenstein said.Rosenstein didn't quote Mueller in his evening remarks -- like he did in a separate appearance at the University of Baltimore Law School earlier Monday -- but he did borrow a line from Attorney General Bill Barr, aligning himself with Barr's views on the appointment of special counsels.Rosenstein stood by his decision to appoint Mueller and challenged critics to "explain what they would have done with the details we knew at the time.""As acting attorney general, it was my responsibility to make sure that the Department of Justice would conduct an independent investigation; complete it expeditiously; hold perpetrators accountable if warranted; and work with partner agencies to counter foreign agents and deter crimes. We achieved those goals," Rosenstein said.Still, he expressed his displeasure with the process, noting "I disfavor special counsels.""I am glad that I only needed to appoint one in 25 months," Rosenstein said. 3247

Rashad Pratt had been sitting in his SUV nearly seven years ago, near his mother's Chicago home, when a man approached with a gun and shot him in the chest, fatally piercing his heart."It's still an open case," lamented his brother, Dr. Abdullah Pratt, who practices at the University of Chicago Medical Center emergency room, not far from where he grew up on the South Side. "Me personally, of course, I want more resources dedicated. Whether that actually helps or not, I don't know."Across Chicago, some residents are questioning the investigative efforts dedicated to uncovering the truth behind 612

SAN DIEGO, Calif. – What’s usually a marathon for biotech companies is now a full-blown sprint to stop the spread of coronavirus.Kate Broderick, the Senior Vice President of R&D at Inovio Pharmaceuticals in San Diego, remembers the moment she first learned about the mysterious outbreak unfolding thousands of miles away. “Yes, absolutely, distinctly, probably one of those moments you’ll remember forever. I was in my kitchen at home the 31st of December,” said Broderick.She never imagined that two months later it would be the crisis it is today. “Every week I keep thinking it’s going to get better, it’s going to start to tone down a little bit, but in fact, rather than getting better it’s getting worse every week,” said Broderick.Inovio has made headlines before, creating vaccines for Zika, Ebola, and now the coronavirus. After Chinese researchers shared the genetic sequence of COVID-19, Inovio designed a vaccine in just three hours Using its proprietary DNA medicines platform technology. The vaccine was designed to precisely match the DNA sequence of the virus“In an outbreak setting we really don’t have two to three years to wait for a vaccine, so that’s where we come in at Inovio pharmaceuticals, we use DNA medicine technology,” said Broderick.While traditional vaccines use the virus itself, this method puts DNA inside E.coli, which naturally replicates the medicine over and over. The paste is then purified, leaving behind only the DNA medicine, which Inovio hopes to test in humans next month.“Infectious diseases are global and they don’t care about boundaries and borders, everyone is affected from childhood all the way through seniors,” said Phyllis Arthur, who’s been in the infectious disease industry for 20 years.Arthur is Vice President of Infectious Diseases and Diagnostic Policy at BIO, an association made up of about 1,000 companies.“One of the things we’re seeing, from outbreak to outbreak, unfortunately, is we’re getting faster at using platform technologies to build something that can be tried in humans sooner than we were the last time,” said Arthur.She’s following dozens of companies working on vaccines, treatments, and diagnostic tools. If their vaccines work, companies like Inovio will have to figure out how to manufacture them fast.“You may have the best vaccine in the world, but if you can only produce 1,000 doses of it, that’s not really going to help 1.4 billion people in China,” said Broderick. Continued funding will also be critical. Broderick says while their Zika vaccine looked promising in humans, it never ultimately got FDA approval for broad public use.“The problem there was, although great for global health, was that of course cases of the virus really steadily declined, the problem for us there was so did the funding,” said Broderick.She says that way of thinking is shortsighted but does see change on the horizon. “It’s a huge amount of responsibility on everyone’s shoulders, and I think we feel genuinely compelled to do everything in our power, hence why no one complains about two hours of sleep, because this is a point in our careers we can truly, literally, make a difference in saving lives, right now,” said Broderick.After the company begins human trials in the U.S., they’ll continue testing in China and South Korea. They hope to deliver one million doses by the end of the year.If they make it that far, it too would be a day Broderick will never forget. 3462

Statements from #Patriots Chairman and CEO Robert Kraft and Head Coach Bill Belichick on Tom Brady's Patriots career: https://t.co/DFmmbzAIdo pic.twitter.com/flVpDFB4HJ— New England Patriots (@Patriots) March 17, 2020 229